Maryland House Bill 1654 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on March 2 2020 - 25% progression, died in committee
Action: 2020-03-02 - First Reading House Rules and Executive Nominations
Pending: House Rules and Executive Nominations Committee
Text: Latest bill text (Introduced) [PDF]

Requiring a prescriber to notify the Prescription Drug Monitoring Program as to whether the prescriber has received education regarding the risks of opioid use, is aware that an opioid overdose reversal drug is available, and has prescribed or dispensed an opioid overdose reversal drug if the prescriber prescribes or dispenses an opioid in a dosage of 50 morphine milligram equivalents or more; and prohibiting a prescriber from being required to make a certain notification more than once.

Prescription Drug Monitoring Program - Prescribers of Opioids - Notification Requirement

Del. Wendell Beitzel [R]

Del. Dan Cox [R]

Del. Susan Krebs [R]

Date	Chamber	Action
2020-03-02	House	First Reading House Rules and Executive Nominations

HB1654 (Carry Over) 2020-03-02 - First Reading House Rules and Executive Nominations

Chapter	Article	Section	Citation Type	Statute Text
Health - General	21	2A-02	(n/a)	See Bill Text
Health - General	21	2A-04.2	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1654?ys=2020RS
Text	https://mgaleg.maryland.gov/2020RS/bills/hb/hb1654f.pdf